SOMERSET, N.J., Oct. 29, 2013 – The Post-Finasteride Syndrome Foundation is reminding PFS patients to report all persistent side effects to the FDA MedWatch program. MedWatch is the U.S. Food and Drug Administration’s system for detecting safety-hazard signals for pharmaceutical products and medical devices. If a signal is detected, the FDA can issue safety alerts, […]
Tag Archives: cognitive dysfunction
डॉक्टरों ने रिसर्च स्टडीज के लिए पीएफएस मरीजों की भर्ती की
SOMERSET, N.J., June 16, 2014 – Post-finasteride syndrome research initiatives at two major U.S. medical institutions, Brigham and Women’s Hospital (a Harvard Medical School Teaching Affiliate) in Boston, Mass., and Baylor College of Medicine in Houston, Texas, are currently recruiting patients for their respective studies on the condition. If you are interested in participating, or […]
फरवरी 2013 से सार इटली में पीएफएस गोलमेज अनुसंधान चर्चा
Aug. 4, 2013 Dear Friends: When we incorporated the Post-Finasteride Syndrome Foundation in July 2012, our mission was clear: To fund research on the characterization, underlying biologic mechanisms and treatments of PFS while raising public awareness of this often life-altering condition afflicting thousands of men the world over. Now, on the occasion of our one-year […]
फाउंडेशन ने पोस्ट-फ़ाइनस्टराइड सिंड्रोम में फंड रिसर्च के लिए वेबसाइट लॉन्च की
The Post-Finasteride Syndrome Foundation today launched its website, PFSFoundation.org. The Post-Finasteride Syndrome Foundation is dedicated to helping fund research on the characterization, underlying biologic mechanisms and treatments of the post-finasteride syndrome (PFS).